Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jennifer M Atkinson

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Breast Cancer Research : BCR|June 27, 2020
Patient treatment and outcome after breast cancer orbital and periorbital metastases: a comprehensive case series including analysis of lobular versus ductal tumor histologyMartin Blohmer, Li Zhu, Jennifer M Atkinson, et al.
Disease Models & Mechanisms|April 7, 2026
Identification and credentialing of invasive lobular carcinoma patient-derived Xenograft modelsJagmohan Hooda, Jennifer M Atkinson, Osama Shiraz Shah, et al.
Biorxiv : the Preprint Server for Biology|September 5, 2025
Identification and Credentialing of Patient Derived Xenograft Models of Invasive Lobular Breast Carcinoma using Multi-omics and Histopathology assessmentJagmohan Hooda, Jennifer M Atkinson, Osama Shiraz Shah, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 27, 2018
Loss of E-cadherin Enhances IGF1-IGF1R Pathway Activation and Sensitizes Breast Cancers to Anti-IGF1R/InsR InhibitorsAlison M Nagle, Kevin M Levine, Nilgun Tasdemir, et al.
Molecular Cancer Research : MCR|March 17, 2023
FOXA1 Reprogramming Dictates Retinoid X Receptor Response in ESR1-Mutant Breast CancerYang Wu, Zheqi Li, Abdalla M Wedn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2021
Prognostic Utility of Breast Cancer Index to Stratify Distant Recurrence Risk in Invasive Lobular CarcinomaRaquel Nunes, Tal Sella, Kai Treuner, et al.
Nature Communications|July 22, 2018
An autophagy assay reveals the ESCRT-III component CHMP2A as a regulator of phagophore closureYoshinori Takahashi, Haiyan He, Zhenyuan Tang, et al.
Endocrinology|July 2, 2020
Differential Regulation and Targeting of Estrogen Receptor α Turnover in Invasive Lobular Breast CarcinomaSreeja Sreekumar, Kevin M Levine, Matthew J Sikora, et al.
Cancer Letters|June 24, 2019
Frequent amplifications of ESR1, ERBB2 and MDM4 in primary invasive lobular breast carcinomaLan Cao, Ahmed Basudan, Matthew J Sikora, et al.
Blood|May 13, 2020
Glucocorticoids enhance the antileukemic activity of FLT3 inhibitors in FLT3-mutant acute myeloid leukemiaMelat T Gebru, Jennifer M Atkinson, Megan M Young, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Breast Cancer Research : BCR|June 27, 2020
Patient treatment and outcome after breast cancer orbital and periorbital metastases: a comprehensive case series including analysis of lobular versus ductal tumor histologyMartin Blohmer, Li Zhu, Jennifer M Atkinson, et al.
Disease Models & Mechanisms|April 7, 2026
Identification and credentialing of invasive lobular carcinoma patient-derived Xenograft modelsJagmohan Hooda, Jennifer M Atkinson, Osama Shiraz Shah, et al.
Biorxiv : the Preprint Server for Biology|September 5, 2025
Identification and Credentialing of Patient Derived Xenograft Models of Invasive Lobular Breast Carcinoma using Multi-omics and Histopathology assessmentJagmohan Hooda, Jennifer M Atkinson, Osama Shiraz Shah, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 27, 2018
Loss of E-cadherin Enhances IGF1-IGF1R Pathway Activation and Sensitizes Breast Cancers to Anti-IGF1R/InsR InhibitorsAlison M Nagle, Kevin M Levine, Nilgun Tasdemir, et al.
Molecular Cancer Research : MCR|March 17, 2023
FOXA1 Reprogramming Dictates Retinoid X Receptor Response in ESR1-Mutant Breast CancerYang Wu, Zheqi Li, Abdalla M Wedn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 11, 2021
Prognostic Utility of Breast Cancer Index to Stratify Distant Recurrence Risk in Invasive Lobular CarcinomaRaquel Nunes, Tal Sella, Kai Treuner, et al.
Nature Communications|July 22, 2018
An autophagy assay reveals the ESCRT-III component CHMP2A as a regulator of phagophore closureYoshinori Takahashi, Haiyan He, Zhenyuan Tang, et al.
Endocrinology|July 2, 2020
Differential Regulation and Targeting of Estrogen Receptor α Turnover in Invasive Lobular Breast CarcinomaSreeja Sreekumar, Kevin M Levine, Matthew J Sikora, et al.
Cancer Letters|June 24, 2019
Frequent amplifications of ESR1, ERBB2 and MDM4 in primary invasive lobular breast carcinomaLan Cao, Ahmed Basudan, Matthew J Sikora, et al.
Blood|May 13, 2020
Glucocorticoids enhance the antileukemic activity of FLT3 inhibitors in FLT3-mutant acute myeloid leukemiaMelat T Gebru, Jennifer M Atkinson, Megan M Young, et al.
Pageof 4